Verato Enrich is powered by the company's cloud-based enterprise master person index. It can append a wide array of data ranging from basic contact information like missing phone numbers and addresses, to lifestyle data like income, ethnicity, race, occupation, and interests to patient records.
Approximately 80% of positive COVID-19 test results are submitted electronically and current reports show that as many as 50% lack enough contact data to support contact tracing.
With Verato Enrich, health systems, commercial labs, and public health teams gain an increased understanding of people and the critical non-clinical factors that impact health.
Enrich acts as an accelerator, enabling contact tracing and analysis to be more efficient and effective. Shortening the cycle between infection notification and actionable data is the only way to ensure a rapid response and contain the virus.
Verato Enrich extends the value proposition of Verato's next-generation EMPI, providing a critical infrastructure backbone for contact tracing and public health analytics, enabling health organisations to accurately integrate information from a range of sources and efficiently drive actionable workflows and information sharing.
Verato is the next generation of EMPI and patient matching.
As a HITRUST-certified EMPI, over 50 of the nation's most innovative healthcare organizations rely on Verato Referential Matching to manage and link person data quickly and at scale.
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support